Difficulty: Medium
Average Score: 80%
Practice
Once-weekly administration of this antibiotic has prophylactic activity against bacteremia due to M avium complex in AIDS patients.
Correct answer
A
Rationale
In this question, the correct answer is A) Azithromycin. Azithromycin is a macrolide antibiotic that is known for its once-weekly dosing regimen and its prophylactic activity against bacteremia caused by Mycobacterium avium complex (MAC) in AIDS patients. This drug is particularly effective in preventing MAC infections in immunocompromised individuals, such as those with AIDS.
Option B) Clarithromycin is also a macrolide antibiotic like azithromycin, but it is typically administered twice daily and is not specifically indicated for once-weekly prophylactic use against MAC infections in AIDS patients.
Option C) Isoniazid is an antibiotic used primarily for the treatment of tuberculosis and is not effective against MAC infections.
Option D) Kanamycin is an aminoglycoside antibiotic that is not commonly used for prophylaxis against MAC infections in AIDS patients.
Educationally, understanding the specific indications and characteristics of chemotherapy drugs is crucial for healthcare professionals, especially those working with immunocompromised populations like AIDS patients. Knowing the appropriate drugs for prophylaxis and treatment can significantly impact patient outcomes and safety. In this case, recognizing the once-weekly dosing and prophylactic activity of azithromycin against MAC in AIDS patients is essential knowledge for healthcare providers involved in the care of these individuals.
Option B) Clarithromycin is also a macrolide antibiotic like azithromycin, but it is typically administered twice daily and is not specifically indicated for once-weekly prophylactic use against MAC infections in AIDS patients.
Option C) Isoniazid is an antibiotic used primarily for the treatment of tuberculosis and is not effective against MAC infections.
Option D) Kanamycin is an aminoglycoside antibiotic that is not commonly used for prophylaxis against MAC infections in AIDS patients.
Educationally, understanding the specific indications and characteristics of chemotherapy drugs is crucial for healthcare professionals, especially those working with immunocompromised populations like AIDS patients. Knowing the appropriate drugs for prophylaxis and treatment can significantly impact patient outcomes and safety. In this case, recognizing the once-weekly dosing and prophylactic activity of azithromycin against MAC in AIDS patients is essential knowledge for healthcare providers involved in the care of these individuals.